Title |
Novel treatment for jaundiced newborns
|
---|---|
Published in |
Pediatrics International, December 2012
|
DOI | 10.1111/j.1442-200x.2012.03726.x |
Pubmed ID | |
Authors |
Tomoyuki Yokota, Ichiro Morioka, Takayuki Kodera, Takeshi Morisawa, Itsuko Sato, Seiji Kawano, Tsubasa Koda, Kiyomi Matsuo, Kazumichi Fujioka, Satoru Morikawa, Akihiro Miwa, Akio Shibata, Naoki Yokoyama, Masahiko Yonetani, Hideto Yamada, Hajime Nakamura, Kazumoto Iijima |
Abstract |
Serum unbound bilirubin (UB) is a measure of bilirubin not bound to albumin, and has been reported to be better than total bilirubin level at identifying infants at risk of developing bilirubin-induced neurotoxicity, including auditory abnormalities. A detailed treatment strategy for newborns with high serum UB has not been established. The aim of this study was to assess auditory outcomes in newborns with serum UB ≥1.00 μg/dL who were treated according to a novel treatment protocol. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
India | 1 | 4% |
Unknown | 27 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Postgraduate | 5 | 18% |
Researcher | 5 | 18% |
Student > Master | 4 | 14% |
Student > Bachelor | 3 | 11% |
Other | 3 | 11% |
Other | 6 | 21% |
Unknown | 2 | 7% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 15 | 54% |
Nursing and Health Professions | 4 | 14% |
Biochemistry, Genetics and Molecular Biology | 3 | 11% |
Agricultural and Biological Sciences | 2 | 7% |
Psychology | 1 | 4% |
Other | 1 | 4% |
Unknown | 2 | 7% |